During the past decade, United Health Services conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 12 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 8 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "United Health Services" #1 sponsor was "Allergan" with 4 trials, followed by "Shire" with 2 trials sponsored, "Alexion" with 1 trials sponsored, "Biophytis" with 1 trials sponsored and "Coloplast A/S" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "United Health Services" #1 collaborator was "Beijing Tiantan Hospital" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "China Medical University Hospital" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Heart and Stroke Foundation of Canada" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "United Health Services" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Myocardial Infarction" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Arteriovenous Fistula" (1 trials). Many other conditions were trialed in "United Health Services" in a lesser frequency.

Most popular intervention types in "United Health Services" are "Drug" (11 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Relamorelin" (3 trials), "Participating Site's standard practice" (2 trials), "SRM003" (2 trials) and "Ancrod (Viprinex)" (1 trials). Other intervention names were less common.

The vast majority of trials in "United Health Services" are 16 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "United Health Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in United Health Services, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in United Health Services, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".